Notably, whereas chemotherapy-induced damage-associated molecular patterns (DAMPs) typically elicit pro-tumor immune responses, APE1-driven Treg recruitment likely counteracts this effect, providing a plausible mechanistic explanation for observed chemoresistance. The gene discussed is APEX1; the disease is neoplasm.